We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003494
Recruitment Status : Terminated (Slow accrual)
First Posted : January 27, 2003
Last Update Posted : January 31, 2018
Information provided by (Responsible Party):
Burzynski Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : May 26, 2002
  Study Completion Date : May 26, 2002